Five patients, three men and two women ranging in age from 22 to 54, with a genetic form of precancerous lesions in the bowel (familial adenomatous polyposis, or FAP) were treated with Oxy-Q over a period of six months in a study funded through a grant from the US National Institutes of Health.
Results showed that the average number of polyps reduced was 60.4% and average size diminished by 50.9%. Both the size and the number of polyps were reduced significantly, which may indicate that Oxy-Q, a unique blend of curcumin and quercetin, could help prevent colon cancer in these patients.
“Although small, this is an important study because it provides clinical evidence that a nutritional supplement with curcumin and quercetin, Oxy-Q, may be as effective as pharmaceuticals in this patient population,” said Dr Marcia Cruz-Correa, one of the lead investigators and assistant professor of medicine at Johns Hopkins University School of Medicine and the University of Puerto Rico Comprehensive Cancer Center. “Although both curcumin and quercetin are found in common foods it is very difficult to eat enough to see a therapeutic benefit.”
Curcumin is found in turmeric and quercetin is found in onions and green tea.